COSCIENS Biopharma Inc.
TSXCSCI heads into May with a striking split: the stock has more than doubled in a month, while short sellers are steadily rebuilding positions and the company prepares to exit US public reporting obligations. The price move is the first thing to understand. CSCI closed at C$2.67 on April 28, up 123% over the past month and a further 2.7% on the day — an extraordinary run for a…
Snapshot as of 11 May 2026
CSCI heads into May with a striking split: the stock has more than doubled in a month, while short sellers are steadily rebuilding positions and the company prepares to exit US public reporting obligations. The price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CSCI — free to start on ORTEX.
Sign up for free →Open CSCI on ORTEX